D. Weiss

Understanding inhaled Technosphere Insulin: Results of an early randomized trial in type 1 diabetes mellitus

B. Hoogwerf, J. McGill, D. Kendall, 2020, Journal of diabetes.

Changes in weight control behaviors and hedonic hunger in a commercial weight management program adapted for individuals with type 2 diabetes

K. Fujioka, L. Aronne, T. Wadden, 2020, International Journal of Obesity.

Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Lawrence A Leiter, J. Fleg, P. O’Connor, 2007, The American journal of cardiology.

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial

Rodica Pop-Busui, Faramarz Ismail-Beigi, Robert Cuddihy, 2010, The Lancet.

Randomized controlled trial of a nationally available weight control program tailored for adults with type 2 diabetes

Peter W. Tuerk, K. Fujioka, T. Wadden, 2016, Obesity.

Impact on psychosocial outcomes of a nationally available weight management program tailored for individuals with type 2 diabetes: Results of a randomized controlled trial.

Peter W. Tuerk, K. Fujioka, T. Wadden, 2017, Journal of diabetes and its complications.

Paradoxical Reduction in HDL-C With Fenofibrate and Thiazolidinedione Therapy in Type 2 Diabetes: The ACCORD Lipid Trial

Lawrence A Leiter, P. O’Connor, R. Byington, 2014, Diabetes Care.